7NIM image
Deposition Date 2021-02-12
Release Date 2021-08-18
Last Version Date 2024-01-31
Entry Detail
PDB ID:
7NIM
Keywords:
Title:
X-ray crystal structure of LsAA9A - cinnamon extract soak
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.45 Å
R-Value Free:
0.18
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 41 3 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Auxiliary activity 9
Gene (Uniprot):LPMO9A
Chain IDs:A
Chain Length:235
Number of Molecules:1
Biological Source:Lentinus similis
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
HIC A HIS modified residue
Primary Citation
Inhibition of lytic polysaccharide monooxygenase by natural plant extracts.
New Phytol. 232 1337 1349 (2021)
PMID: 34389999 DOI: 10.1111/nph.17676

Abstact

Lytic polysaccharide monooxygenases (LPMOs) are monocopper enzymes of industrial and biological importance. In particular, LPMOs play important roles in fungal lifestyle. No inhibitors of LPMOs have yet been reported. In this study, a diverse library of 100 plant extracts was screened for LPMO activity-modulating effects. By employing protein crystallography and LC-MS, we successfully identified a natural LPMO inhibitor. Extract screening revealed a significant LPMO inhibition by methanolic extract of Cinnamomum cassia (cinnamon), which inhibited LsAA9A LPMO from Lentinus similis in a concentration-dependent manner. With a notable exception, other microbial LPMOs from families AA9 and AA10 were also inhibited by this cinnamon extract. The polyphenol cinnamtannin B1 was identified as the inhibitory component by crystallography. Cinnamtannin B1 was bound to the surface of LsAA9A at two distinct binding sites: one close to the active site and another at a pocket on the opposite side of the protein. Independent characterization of cinnamon extract by LC-MS and subsequent activity measurements confirmed that the compound inhibiting LsAA9A was cinnamtannin B1. The results of this study show that specific natural LPMO inhibitors of plant origin exist in nature, providing the opportunity for future exploitation of such compounds within various biotechnological contexts.

Legend

Protein

Chemical

Disease

Primary Citation of related structures